Evidence map›Paper›PMID 36628034›Full record

ArticleCureus2022

High Adenoma Detection Rates in Fecal Immunochemical Test-Based Colorectal Cancer Screening: Interim Results of the National Bowel Cancer Screening Program in Qatar.

Anil K John, Betsy Varughese, Shaikha S Abushaikha, Ahed M Hamdan, Viswapriya Pillai, Ahmad M Ayash, Paul K Vincent, Khaleel Sultan, Khalid M Al Ejji, Rajvir Singh and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Anil K JohnGastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
Betsy VarugheseGastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
Shaikha S AbushaikhaCommunity Medicine, Primary Health Care Corporation, Doha, QAT.
Ahed M HamdanPreventative Health Screening Programs, Primary Health Care Corporation, Doha, QAT.
Viswapriya PillaiGastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
Ahmad M AyashGastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
Paul K VincentGastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
Khaleel SultanGastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
Khalid M Al EjjiGastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
Rajvir SinghCardiology Research, Heart Hospital, Hamad Medical Corporation, Doha, QAT.
Samya AlabdullaFamily Medicine, Primary Health Care Corporation, Doha, QAT.
Mariam AbdulmalikFamily Medicine, Primary Health Care Corporation, Doha, QAT.
Saad Al KaabiGastroenterology and Hepatology, Hamad Medical Corporation, Doha, QAT.
Primary Health Care · QAHamad Medical Corporation · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionColorectal cancer is one of the most common cancers globally. Recent reductions in mortality rates have been primarily attributed to screening programs. The State of Qatar established a national bowel cancer screening program in 2016. METHODOLOGY: Fecal immunochemical testing (FIT) was used for average-risk individuals aged 50 to 74 years. Fecal immunochemical testing -positive participants were referred for total colonoscopy to detect polyps and cancers.

resultsAmong 32,751 FIT invitees, 11,130 took the test, and 758 (6%) of those were FIT positive. Of these, 375 (56.13%) participants underwent a colonoscopy, and polyps were detected in 198 (52.8%) and cancers in 19 (5.1%) participants. The adenoma detection rate exceeded 40%. DISCUSSION AND

conclusionThe high yield of polyps and cancers in the screening program justifies an active, resource-intensive, and organized bowel cancer screening effort. The high adenoma detection rate in a FIT-based program warrants recalibration of target adenoma detection rates in screening programs.

Indexed as

adenoma detectionbowel cancer screeningcolorectal cancercrcfecal immunochemical test

Identifiers

PMID36628034
PMCPMC9822526
OpenAlexW4311847335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.